Access To Medicines Impacted In Iran Following Tightening Of U.S. Sanctions
New York Times: Iranians Fear Medicine Shortages as U.S. Tightens Sanctions
“…Anxieties over the availability of medicine are mounting in Iran with the reimposition this month of sanctions by the United States after President Trump withdrew from the nuclear deal. Harsh banking restrictions and the threat of secondary sanctions for companies doing business with Iran have made it nearly impossible for foreign pharmaceutical companies to continue working in the country. Trump administration officials say that the sanctions will not affect trade in humanitarian items, but many are skeptical…” (Tabrizy, 11/11).